120PComparison of model-based dose escalation design with rule-based design of phase I oncology trials. (5th March 2018) - Shimomura, A; Ebata, T; Koyama, T; Iwasa, S; Kondo, S; Kitano, S; Yonemori, K; Fujiwara, Y; Shimizu, T; Yamamoto, N